approval of unaudited financial results for the quarter ended December 31 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Sharma East India Hospitals approved its Q3 FY26 (quarter ended Dec 31, 2025) standalone unaudited results. Revenue from operations rose to Rs. 960.88 lakhs, up about 18% from Rs. 815.07 lakhs in the same quarter last year. However, profit after tax fell sharply to Rs. 17.77 lakhs (vs Rs. 28.77 lakhs YoY), and also dropped from Rs. 31.78 lakhs in the previous quarter. On a 9-month basis, revenue grew to Rs. 2,846.70 lakhs (from Rs. 2,388.81 lakhs), but 9-month profit slipped to Rs. 81.35 lakhs from Rs. 87.74 lakhs. The auditor (Gopal Sharma & Co.) issued a clean limited review report with no qualifications.
Despite healthy top-line growth, shrinking margins and falling profits signal rising costs squeezing the hospital's profitability. Short-term sentiment may be mildly negative for shareholders, though the clean audit and continued revenue expansion provide some comfort.